• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson's disease.功能性儿茶酚-O-甲基转移酶基因型在中国帕金森病患者中的作用。
Transl Neurodegener. 2017 Apr 26;6:11. doi: 10.1186/s40035-017-0081-9. eCollection 2017.
2
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.功能性儿茶酚-O-甲基转移酶单倍型与帕金森病风险、左旋多巴治疗反应及并发症的关联。
Pharmacogenet Genomics. 2008 Sep;18(9):815-21. doi: 10.1097/FPC.0b013e328306c2f2.
3
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.儿茶酚-O-甲基转移酶单核苷酸多态性和单倍型对重性抑郁障碍治疗反应表型的影响:病例对照关联研究。
Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.
4
Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson's disease.儿茶酚-O-甲基转移酶(COMT)基因变异与帕金森病患者的认知能力下降有关。
Parkinsonism Relat Disord. 2018 May;50:48-53. doi: 10.1016/j.parkreldis.2018.02.015. Epub 2018 Feb 9.
5
Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson's Disease.帕金森病患者中儿茶酚-O-甲基转移酶基因多态性及单倍型与左旋多巴诱发不良事件的关联
Indian J Clin Biochem. 2023 Apr;38(2):262-274. doi: 10.1007/s12291-022-01046-8. Epub 2022 May 2.
6
COMT gene haplotypes are closely associated with postoperative fentanyl dose in patients.儿茶酚-O-甲基转移酶基因单倍型与患者术后芬太尼剂量密切相关。
Anesth Analg. 2015 Apr;120(4):933-40. doi: 10.1213/ANE.0000000000000563.
7
Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.COMT、MTHFR 和 SLC19A1(RFC-1) 多态性与帕金森病患者同型半胱氨酸血水平和认知障碍的关联。
Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7.
8
Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease.儿茶酚-O-甲基转移酶基因的遗传变异与中国帕金森病患者左旋多巴反应的可变性有关。
Sci Rep. 2020 Jun 12;10(1):9521. doi: 10.1038/s41598-020-65332-2.
9
Association Between Catechol-O-Methyltransferase (COMT) Gene Polymorphisms, Parkinson's Disease, and Levodopa Efficacy.儿茶酚-O-甲基转移酶(COMT)基因多态性、帕金森病与左旋多巴疗效之间的关联
Mol Diagn Ther. 2013 Nov 15. doi: 10.1007/s40291-013-0066-z.
10
Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson's disease.抑郁和儿茶酚-O-甲基转移酶(COMT)基因变异与帕金森病的疼痛有关。
Sci Rep. 2017 Jul 24;7(1):6306. doi: 10.1038/s41598-017-06782-z.

引用本文的文献

1
Gene Polymorphisms of Parkinson's Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder.帕金森病风险位点与特发性快速眼动睡眠行为障碍的基因多态性
Biomedicines. 2025 Mar 24;13(4):788. doi: 10.3390/biomedicines13040788.
2
Importance of Using Epigenetic Nutrition and Supplements Based on Nutrigenetic Tests in Personalized Medicine.在个性化医疗中基于营养基因检测使用表观遗传营养和补充剂的重要性。
Cureus. 2024 Aug 15;16(8):e66959. doi: 10.7759/cureus.66959. eCollection 2024 Aug.
3
Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson's Disease.帕金森病患者中儿茶酚-O-甲基转移酶基因多态性及单倍型与左旋多巴诱发不良事件的关联
Indian J Clin Biochem. 2023 Apr;38(2):262-274. doi: 10.1007/s12291-022-01046-8. Epub 2022 May 2.
4
Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis.COMT rs4680 和 MAO-B rs1799836 多态性与帕金森病患者左旋多巴诱导的运动障碍的关联:一项荟萃分析。
Neurol Sci. 2021 Oct;42(10):4085-4094. doi: 10.1007/s10072-021-05509-3. Epub 2021 Aug 4.
5
Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease.多巴脱羧酶基因多态性改变中国帕金森病患者对左旋多巴的运动反应。
Front Neurol. 2020 Oct 29;11:520934. doi: 10.3389/fneur.2020.520934. eCollection 2020.
6
Meta-Analysis of the Effects of the Catechol-O-Methyltransferase Val158/108Met Polymorphism on Parkinson's Disease Susceptibility and Cognitive Dysfunction.儿茶酚-O-甲基转移酶Val158/108Met多态性对帕金森病易感性和认知功能障碍影响的Meta分析
Front Genet. 2019 Jul 12;10:644. doi: 10.3389/fgene.2019.00644. eCollection 2019.
7
The Moderating Role of COMT and BDNF Polymorphisms on Transfer Effects Following Multi- and Single-Domain Cognitive Training Among Community-Dwelling Shanghainese Older Adults.儿茶酚-O-甲基转移酶(COMT)和脑源性神经营养因子(BDNF)基因多态性对上海社区老年人多领域和单领域认知训练后迁移效应的调节作用
Front Aging Neurosci. 2018 Jul 5;10:198. doi: 10.3389/fnagi.2018.00198. eCollection 2018.

本文引用的文献

1
COMT gene haplotypes are closely associated with postoperative fentanyl dose in patients.儿茶酚-O-甲基转移酶基因单倍型与患者术后芬太尼剂量密切相关。
Anesth Analg. 2015 Apr;120(4):933-40. doi: 10.1213/ANE.0000000000000563.
2
Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.儿茶酚-O-甲基转移酶(COMT)基因Val158Met多态性与帕金森病剂末现象易感性的关联
Neurol Sci. 2015 Apr;36(4):621-3. doi: 10.1007/s10072-014-1998-8. Epub 2014 Nov 4.
3
Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.儿茶酚-O-甲基转移酶Val158Met基因多态性:中国帕金森病队列中剂末现象易感性的调节
Parkinsonism Relat Disord. 2014 Oct;20(10):1094-6. doi: 10.1016/j.parkreldis.2014.07.011. Epub 2014 Jul 27.
4
Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.亚洲人群中儿茶酚-O-甲基转移酶(COMT)基因Val158Met多态性与帕金森病风险
Neurol Sci. 2015 Jan;36(1):109-15. doi: 10.1007/s10072-014-1896-0. Epub 2014 Jul 25.
5
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.中国人群中儿茶酚-O-甲基转移酶和单胺氧化酶B基因多态性与帕金森病运动并发症的关联
Parkinsonism Relat Disord. 2014 Oct;20(10):1041-5. doi: 10.1016/j.parkreldis.2014.06.021. Epub 2014 Jul 4.
6
COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis.COMT 基因与帕金森病风险:系统评价和荟萃分析。
Pharmacogenet Genomics. 2014 Jul;24(7):331-9. doi: 10.1097/FPC.0000000000000056.
7
Prevalence of malnutrition in patients with Parkinson's disease: a comparative study with healthy controls using Mini Nutritional Assessment (MNA) questionnaire.帕金森病患者营养不良的患病率:一项使用微型营养评定法(MNA)问卷对帕金森病患者与健康对照者进行的比较研究。
J Parkinsons Dis. 2014;4(3):473-81. doi: 10.3233/JPD-130323.
8
Association Between Catechol-O-Methyltransferase (COMT) Gene Polymorphisms, Parkinson's Disease, and Levodopa Efficacy.儿茶酚-O-甲基转移酶(COMT)基因多态性、帕金森病与左旋多巴疗效之间的关联
Mol Diagn Ther. 2013 Nov 15. doi: 10.1007/s40291-013-0066-z.
9
The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations.COMT Val158Met 多态性是亚洲人群而非高加索人群帕金森病的相关风险因素。
Neurol India. 2013 Jan-Feb;61(1):12-6. doi: 10.4103/0028-3886.108121.
10
Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.单胺氧化酶 B 和儿茶酚-O-甲基转移酶多态性与伊朗人群散发性帕金森病的关联。
Folia Neuropathol. 2012;50(4):382-9. doi: 10.5114/fn.2012.32368.

功能性儿茶酚-O-甲基转移酶基因型在中国帕金森病患者中的作用。

Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson's disease.

作者信息

Xiao Qin, Qian Yiwei, Liu Jiujiang, Xu Shaoqing, Yang Xiaodong

机构信息

Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine, No. 197, Ruijin Er Road, Shanghai, 200025 China.

出版信息

Transl Neurodegener. 2017 Apr 26;6:11. doi: 10.1186/s40035-017-0081-9. eCollection 2017.

DOI:10.1186/s40035-017-0081-9
PMID:28451382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5405521/
Abstract

BACKGROUND

Recent studies have found that the functional catechol-O-methyltransferase (COMT) gene may be associated with the susceptibility to and pharmacotherapy of Parkinson's disease (PD). In this case-control study, we investigated the most common functional COMT gene haplotypes that had been shown to influence COMT enzymatic activity and the association of the single and combined COMT haplotypes with clinical symptoms and pharmacotherapy in Chinese patients with PD.

METHODS

One hundred forty-three patients with idiopathic PD and 157 healthy individuals were enrolled in this study. Four single nucleotide polymorphisms (SNPs) in the COMT gene (formed by SNPs) were genotyped in each participant: rs6269 A > G; rs4633 C > T; rs4818 C > G; and rs4680 G > A.

RESULTS

The frequencies of rs4633 T carriers, rs4680 A carriers and the two linked rs4633-rs4680 T/A carriers were significantly higher in the early onset PD group than in the healthy controls (all  < 0.05). Homozygosity for rs4633 (TT), rs4680 (AA) and of the two linked rs4633-rs4680 (TT/AA) was significantly more frequent in patients who exhibited the "wearing-off" phenomenon, longer disease duration, higher levodopa equivalent doses (LED) and higher Unified Parkinson's Disease Rating Scale (UPDRS) scores ( < 0.05). No significant differences were observed in the clinical features of patients who carried individual rs6269 and rs4818, the two linked rs6269-rs4818 and the four combined COMT SNPs.

CONCLUSIONS

The results showed a possible association of combined functional COMT SNPs with PD risk, disease duration, the "wearing-off" phenomenon, daily LEDs and higher UPDRS scores, which may be useful in instituting individualized therapy for patients with PD.

摘要

背景

近期研究发现,功能性儿茶酚-O-甲基转移酶(COMT)基因可能与帕金森病(PD)的易感性及药物治疗相关。在这项病例对照研究中,我们调查了已被证明会影响COMT酶活性的最常见功能性COMT基因单倍型,以及中国PD患者中单一和联合COMT单倍型与临床症状及药物治疗的关联。

方法

本研究纳入了143例特发性PD患者和157名健康个体。对每位参与者的COMT基因中的四个单核苷酸多态性(SNP,由这些SNP构成)进行基因分型:rs6269 A>G;rs4633 C>T;rs4818 C>G;以及rs4680 G>A。

结果

早发型PD组中rs4633 T携带者、rs4680 A携带者以及两个连锁的rs4633 - rs4680 T/A携带者的频率显著高于健康对照组(均P<0.05)。在出现“剂末现象”、病程较长、左旋多巴等效剂量(LED)较高以及统一帕金森病评定量表(UPDRS)评分较高的患者中,rs4633(TT)、rs4680(AA)以及两个连锁的rs4633 - rs4680(TT/AA)的纯合子频率显著更高(P<0.05)。携带单个rs6269和rs4818、两个连锁的rs6269 - rs4818以及四个联合的COMT SNP的患者的临床特征未观察到显著差异。

结论

结果显示功能性COMT SNP联合可能与PD风险、病程、“剂末现象”、每日LED以及较高的UPDRS评分相关,这可能有助于为PD患者制定个体化治疗方案。